These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19696299)

  • 1. Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition.
    Jansen SA; Shimauchi A; Zak L; Fan X; Wood AM; Karczmar GS; Newstead GM
    AJR Am J Roentgenol; 2009 Sep; 193(3):832-9. PubMed ID: 19696299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.
    Wang LC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Sep; 193(3):826-31. PubMed ID: 19696298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
    Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
    Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic breast MRI: does lower temporal resolution negatively affect clinical kinetic analysis?
    Gutierrez RL; Strigel RM; Partridge SC; DeMartini WB; Eby PR; Stone KM; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2012 Sep; 199(3):703-8. PubMed ID: 22915415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
    Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
    Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of an ultrafast breast MRI protocol in the differentiation of benign and malignant breast lesions.
    Ramli Hamid MT; Ab Mumin N; Wong YV; Chan WY; Rozalli FI; Rahmat K
    Clin Radiol; 2023 Jun; 78(6):444-450. PubMed ID: 37029001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
    Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
    Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers.
    Bhooshan N; Giger ML; Jansen SA; Li H; Lan L; Newstead GM
    Radiology; 2010 Mar; 254(3):680-90. PubMed ID: 20123903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
    Chen W; Giger ML; Bick U; Newstead GM
    Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.
    Viehweg P; Lampe D; Buchmann J; Heywang-Köbrunner SH
    MAGMA; 2000 Dec; 11(3):129-37. PubMed ID: 11154954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
    Choi N; Han BK; Choe YH; Kim HS
    J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis.
    Vag T; Baltzer PA; Dietzel M; Benndorf M; Gajda M; Camara O; Kaiser WA
    Acta Radiol; 2010 Nov; 51(9):955-61. PubMed ID: 20942728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast.
    Jansen SA; Shimauchi A; Zak L; Fan X; Karczmar GS; Newstead GM
    J Magn Reson Imaging; 2011 Jun; 33(6):1382-9. PubMed ID: 21591007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
    Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
    Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI.
    Fan X; Medved M; Karczmar GS; Yang C; Foxley S; Arkani S; Recant W; Zamora MA; Abe H; Newstead GM
    Magn Reson Imaging; 2007 Jun; 25(5):593-603. PubMed ID: 17540270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement?
    Jansen SA; Fan X; Karczmar GS; Abe H; Schmidt RA; Giger M; Newstead GM
    Med Phys; 2008 Jul; 35(7):3102-9. PubMed ID: 18697535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment.
    Abe H; Mori N; Tsuchiya K; Schacht DV; Pineda FD; Jiang Y; Karczmar GS
    AJR Am J Roentgenol; 2016 Nov; 207(5):1159-1166. PubMed ID: 27532897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions.
    Partridge SC; Stone KM; Strigel RM; DeMartini WB; Peacock S; Lehman CD
    Acad Radiol; 2014 Sep; 21(9):1195-203. PubMed ID: 24998690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.